Skip to main content

UBS Group AG

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in SYRE

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$33,857,092
+$11,561,751 QoQ
Shares Held
671,235
-1.4% QoQ
Ownership
0.773%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. SYRE ranks #52 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SYRE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $33,857,092 671,235
2025-12-31 $22,295,341 680,566
2025-09-30 $6,462,470 385,589
2025-06-30 $6,929,059 462,863
2025-03-31 $8,910,440 552,243
2024-12-31 $9,130,345 392,197
2024-09-30 $1,701,014 57,838
2024-06-30 $1,046,289 44,504
2024-03-31 $98,655 2,601
2023-12-31 $80,183 3,726